UnitedHealth Group Incorporated $UNH Shares Sold by Summa Corp.

Summa Corp. trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 15.8% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,250 shares of the healthcare conglomerate’s stock after selling 235 shares during the period. Summa Corp.’s holdings in UnitedHealth Group were worth $390,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Citizens National Bank Trust Department grew its stake in UnitedHealth Group by 1.0% in the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock worth $9,368,000 after purchasing an additional 170 shares in the last quarter. Caitlin John LLC boosted its stake in UnitedHealth Group by 14.8% in the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock valued at $451,000 after acquiring an additional 111 shares during the period. Triumph Capital Management acquired a new position in UnitedHealth Group in the second quarter valued at approximately $1,324,000. Wealth Effects LLC boosted its stake in UnitedHealth Group by 14.4% in the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after acquiring an additional 591 shares during the period. Finally, Arlington Partners LLC acquired a new position in UnitedHealth Group in the second quarter valued at approximately $2,229,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the company. Weiss Ratings restated a “sell (d+)” rating on shares of UnitedHealth Group in a research note on Wednesday. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Piper Sandler cut their price target on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a report on Wednesday, July 30th. Baird R W cut UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Finally, Morgan Stanley lifted their price target on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a report on Friday, September 12th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have assigned a Sell rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group presently has an average rating of “Hold” and a consensus price target of $383.09.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $354.30 on Friday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The stock has a market cap of $320.88 billion, a price-to-earnings ratio of 15.35, a PEG ratio of 2.29 and a beta of 0.47. The stock’s 50 day moving average price is $318.21 and its 200 day moving average price is $349.25. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the previous year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.